PAPER Olde Rikkert MG, Verhey FR, Sijben JW, Bouwman FH, Dautzenberg PL, Lansink M, Sipers WM, van Asselt DZ, van Hees AM, Stevens M, Vellas B, Scheltens P
SEARCH RESULTS
330026 RESULTS
PAPER Sauvée M, DidierLaurent G, Latarche C, Escanyé MC, Olivier JL, Malaplate-Armand C
Additional use of Aβ₄₂/Aβ₄₀ ratio with cerebrospinal fluid biomarkers P-tau and Aβ₄₂ increases the level of evidence of Alzheimer's disease pathophysiological process in routine practice.
J Alzheimers Dis. 2014;41(2):377-86. PubMed: 24614902PAPER Boespflug EL, Eliassen J, Welge J, Krikorian R
Associative learning and regional white matter deficits in mild cognitive impairment.
J Alzheimers Dis. 2014;41(2):421-30. PubMed: 24614901PAPER Evangelisti E, Zampagni M, Cascella R, Becatti M, Fiorillo C, Caselli A, Bagnoli S, Nacmias B, Cecchi C
Plasma membrane injury depends on bilayer lipid composition in Alzheimer's disease.
J Alzheimers Dis. 2014;41(1):289-300. PubMed: 24614900PAPER Ando K, Kabova A, Stygelbout V, Leroy K, Heraud C, Frédérick C, Suain V, Yilmaz Z, Authelet M, Dedecker R, Potier MC, Duyckaerts C, Brion JP
Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
J Alzheimers Dis. 2014;40 Suppl 1:S135-45. PubMed: 24614899PAPER Alonso R, Pisa D, Marina AI, Morato E, Rábano A, Carrasco L
Fungal infection in patients with Alzheimer's disease.
J Alzheimers Dis. 2014;41(1):301-11. PubMed: 24614898PAPER Tajes M, Eraso-Pichot A, Rubio-Moscardó F, Guivernau B, Ramos-Fernández E, Bosch-Morató M, Guix FX, Clarimón J, Miscione GP, Boada M, Gil-Gómez G, Suzuki T, Molina H, Villà-Freixa J, Vicente R, Muñoz FJ
Methylglyoxal produced by amyloid-β peptide-induced nitrotyrosination of triosephosphate isomerase triggers neuronal death in Alzheimer's disease.
J Alzheimers Dis. 2014;41(1):273-88. PubMed: 24614897PAPER Lim JS, Park YH, Jang JW, Park SY, Kim S, Alzheimer's Disease Neuroimaging Initiative
Differential white matter connectivity in early mild cognitive impairment according to CSF biomarkers.
PLoS One. 2014;9(3):e91400. Epub 2014 Mar 10 PubMed: 24614676PAPER Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A, Hur JY, Zheng H, Li H, Fine R, Mwamburi M, Sun X, Kowall N, Stern RA, Qiu WQ
Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.
Mol Psychiatry. 2014 Mar 11; PubMed: 24614496PAPER Doraiswamy PM, Sperling RA, Johnson K, Reiman EM, Wong TZ, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Joshi AD, Lu M, Grundman M, Mintun MA, Skovronsky DM, Pontecorvo MJ, AV45-A11 Study Group, AV45-A11 Study Group
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.
Mol Psychiatry. 2014 Sep;19(9):1044-51. Epub 2014 Mar 11 PubMed: 24614494PAPER Tateno A, Sakayori T, Okubo Y
Amyloid positron emission tomography imaging for the differential diagnosis of Alzheimer's disease.
J Nippon Med Sch. 2014;81(1):2-3. PubMed: 24614388PAPER Tierney MC, Naglie G, Upshur R, Moineddin R, Charles J, Jaakkimainen RL
Feasibility and Validity of the Self-administered Computerized Assessment of Mild Cognitive Impairment With Older Primary Care Patients.
Alzheimer Dis Assoc Disord. 2014 Mar 24; PubMed: 24614274PAPER Toepper M, Steuwe C, Beblo T, Bauer E, Boedeker S, Thomas C, Markowitsch HJ, Driessen M, Sammer G
Deficient Symbol Processing in Alzheimer Disease.
Alzheimer Dis Assoc Disord. 2014 Mar 7; PubMed: 24614273PAPER Romero HR, Welsh-Bohmer KA, Gwyther LP, Edmonds HL, Plassman BL, Germain CM, McCart M, Hayden KM, Pieper C, Roses AD
Community engagement in diverse populations for Alzheimer disease prevention trials.
Alzheimer Dis Assoc Disord. 2014 Jul-Sep;28(3):269-74. PubMed: 24614272PAPER Gilca M, Lixandru D, Gaman L, Vîrgolici B, Atanasiu V, Stoian I
Erythrocyte Membrane Stability to Hydrogen Peroxide is Decreased in Alzheimer Disease.
Alzheimer Dis Assoc Disord. 2014 Mar 7; PubMed: 24614270Current Filters
No filters selected